Zymeworks Inc. (ZYME) CEO Ken Galbraith on Q2 2022 Results - Earnings Call Transcript

Zymeworks Inc. (NYSE:NYSE:ZYME) Q2 2022 Results Conference Call August 04, 2022 04:30 PM ET Company Participants Jack Spinks - Associate Director of Investor Relations Ken Galbraith - Chair...

Related Keywords

Paris ,France General ,France ,New York ,United States ,Memorial Sloan Kettering Cancer Center ,Vancouver ,British Columbia ,Canada ,Delaware ,New York Stock Exchange ,Canadian ,American ,Ken Galbraith ,Neil Josephson ,Paul Moore ,Stephen Willey ,Akash Tewari ,Komal Jhaveri ,Gena Wang ,Charles Zhu ,Neil Klompas ,Amy Li ,Yigal Nochomovitz ,Jack Spinks ,Nick Abbott ,Company Participants ,York Stock Exchange ,Zymeworks Inc ,European Society Of Medical Oncology ,European Society For Medical Oncology Conference ,Zymeworks Delaware Inc ,Barclays ,Wells Fargo ,Conference Call August ,Zymeworks Second Quarter ,Conference Call ,Associate Director ,Investor Relations ,Zymeworks Delaware ,Chief Executive Officer ,Chief Operating ,Chief Scientific ,Chief Scientific Officer ,Annual Meeting ,American Society ,Clinical Oncology ,European Society ,Medical Oncology ,Medical Oncology Conference ,